Cited by 70Neurotransmitter Receptor Influence on BehaviorParkinson's Disease Mechanisms and TreatmentsNeuroscience and Neuropharmacology Research

Combinatorial Expression of Grp and Neurod6 Defines Dopamine Neuron Populations with Distinct Projection Patterns and Disease Vulnerability

Open access
Kramer, Daniel J., Risso, Davide, Kosillo, Polina, Ngai, John, Bateup, Helen S.·2018·eNeuro

Abstract

Abstract Midbrain dopamine neurons project to numerous targets throughout the brain to modulate various behaviors and brain states. Within this small population of neurons exists significant heterogeneity based on physiology, circuitry, and disease susceptibility. Recent studies have shown that dopamine neurons can be subdivided based on gene expression; however, the extent to which genetic markers represent functionally relevant dopaminergic subpopulations has not been fully explored. Here we performed single-cell RNA-sequencing of mouse dopamine neurons and validated studies showing that Neurod6 and Grp are selective markers for dopaminergic subpopulations. Using a combination of multiplex fluorescent in situ hybridization, retrograde labeling, and electrophysiology in mice of both sexes, we defined the anatomy, projection targets, physiological properties, and disease vulnerability of dopamine neurons based on Grp and/or Neurod6 expression. We found that the combinatorial expression of Grp and Neurod6 defines dopaminergic subpopulations with unique features. Grp + /Neurod6 + dopamine neurons reside in the ventromedial VTA, send projections to the medial shell of the nucleus accumbens, and have noncanonical physiological properties. Grp + /Neurod6- dopamine neurons are found in the VTA as well as in the ventromedial portion of the SNc, where they project selectively to the dorsomedial striatum. Grp-/Neurod6 + dopamine neurons represent a smaller VTA subpopulation, which is preferentially spared in a 6-OHDA model of Parkinson’s disease. Together, our work provides detailed characterization of Neurod6 and Grp expression in the midbrain and generates new insights into how these markers define functionally relevant dopaminergic subpopulations.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/eneuro.0152-18.2018

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 58 · Cited by 70

Authors
Kramer, D. J., Risso, D., Kosillo, P., Ngai, J., & Bateup, H. S.
Affiliations
  • University of California, Berkeley (US)
  • Weill Cornell Medicine (US)
Corresponding author
Bateup, Helen S.
Venue
eNeuro
Published
2018-05
Volume
5
Issue
3
Pages
ENEURO.0152-18.2018
ISSN
2373-2822 (ISSN-L)
OpenAlex
W2803110575
Cited by
70
References
58
Citations by year
2026: 5 · 2025: 10 · 2024: 15 · 2023: 7 · 2022: 5 · 2021: 14 · 2020: 8 · 2019: 6
FWCI
3.19
Type
journal article
Language
en
Open access
Locations
  • eNeuro (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
  • Padua Research Archive (University of Padova) (submittedVersion, cc-by)
Funders
  • HHS | NIH | National Institute of Mental Health (U01MH105878)
  • Alfred P. Sloan Foundation (FR-2015-65790)
  • Brain and Behavior Research Foundation (25073)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
dopaminergic neurons, GRP, NeuroD6, ventral tegmental area, substantia nigra pars compacta, nucleus accumbens shell, dorsomedial striatum, 6-hydroxydopamine, neuronal heterogeneity, single-cell RNA sequencing, retrograde tracing, electrophysiology
MeSH terms
Animals, Female, Male, Mesencephalon, Mice, Inbred C57BL, Nerve Tissue Proteins, Neural Pathways, Nucleus Accumbens, In Situ Hybridization, Fluorescence, Sequence Analysis, RNA, Ventral Tegmental Area, Gastrin-Releasing Peptide, Basic Helix-Loop-Helix Proteins, Dopaminergic Neurons

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review